知镜 Cognispect · 医学文献与研究工作台

[Interpretation of "Clinical practice guidelines for the treatment and prophylaxis of influenza in China (2025 edition)"].

Wang YM, Li JY, Chen SY, Cao B.
Zhonghua yi xue za zhi · 2026-03-01 · PMID 41668281

文献摘要

"Clinical practice guidelines for the treatment and prophylaxis of influenza in China (2025 edition)" (hereinafter referred to as "the guideline") were jointly released by the Chinese Thoracic Society and Chinese Society of Infectious Diseases of the Chinese Medical Association. As an influenza guideline developed using evidence-based methodology in China, its key strength lies in providing systematic and actionable recommendations grounded in evidence. This article aims to provide a clinical interpretation of the guidelines, highlighting five major advancements compared with previous consensus documents: methodological innovation, stratified treatment strategies, integration of new evidence on domestically developed innovative drugs, clarification of the therapeutic window and explicit preventive strategies. This interpretation is intended to assist clinicians in thoroughly understanding the core principles and clinical considerations of the guideline, thereby promoting effective implementation.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。